Social Media Press Releases
RSS5/01/2012
NEW STUDY DEMONSTRATES DOSING NON-COMPLIANCE INCREASES RSV-RELATED HOSPITALIZATIONS AMONG HIGH-RISK BABIES IN MEDICAID POPULATION
» read more4/02/2012
ASTRAZENECA AND AMGEN ANNOUNCE COLLABORATION TO JOINTLY DEVELOP AND COMMERCIALISE CLINICAL-STAGE INFLAMMATION PORTFOLIO
» read more3/26/2012
MEDIMMUNE TO PRESENT NINE ABSTRACTS RELATED TO INFLUENZA VACCINATION AT FIRST ONLINE NATIONAL IMMUNIZATION CONFERENCE
» read more2/29/2012
MEDIMMUNE ANNOUNCES FDA APPROVAL OF FIRST FOUR-STRAIN FLU VACCINE, FLUMIST® QUADRIVALENT (INFLUENZA VACCINE LIVE, INTRANASAL)
» read more11/28/2011
ASTRAZENECA COMMITS AN ADDITIONAL $100 MILLION TO VENTURE CAPITAL ARM MEDIMMUNE VENTURES
» read more11/08/2011
